Skip to Main Content

Paper Details

A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma.
Int J Radiat Oncol Biol Phys
46
2020
Author NameAffiliation
Nadeem RiazMemorial Sloan Kettering Cancer Center
Sean M McBrideMemorial Sloan Kettering Cancer Center
Nancy Y LeeMemorial Sloan Kettering Cancer Center
Eric J ShermanMemorial Sloan Kettering Cancer Center
Nora KatabiMemorial Sloan Kettering Cancer Center
Richard J WongMemorial Sloan Kettering Cancer Center
Alan L HoMemorial Sloan Kettering Cancer Center
David G PfisterMemorial Sloan Kettering Cancer Center
  • 1 - 8

Datasets

Release 1.2